About Kanwal
As a seasoned leader, I bring over a decade of experience across North America, the Middle East, Africa, and emerging markets. My expertise lies in driving innovation, shaping healthcare strategies, and delivering patient-centric solutions that generate transformative business outcomes.
π
πππ¬ ππππππ©ππ ππ‘π§π¦
πΊππππππππ π·πππ
πππ π³πππππππ:
- Launched breakthrough therapies in Canada, including Abrocitinib and first-in-class molecule, Ritlecitinib.
- Re-launched Geodon, fostering the adoption of metabolic screening algorithms in UAE and Kuwait hospitals.
- Launched Eliquis, complemented by the atrial fibrillation screening program, raising cardiovascular risk awareness.
ππ’π₯πππ©ππͺπ‘ ππ§π€ππππ©π¨:
- Built a regional medical community through 'Empowering NCD Action', engaging 1,500+ healthcare professionals via educational platforms, ad boards, & collaborations with health authorities.
- Led the 'Mapping the Patient Journey' project in 4 countries, generating actionable insights and producing four peer-reviewed publications on managing hypertension and dyslipidemia.
ππ‘π€πππ‘ ππππππ§π¨πππ₯:
- Established partnerships with healthcare authorities, KOLs, and academia to develop compliant, innovative strategies.
- As North Africa Medical Lead, redefined strategies and launched digital campaigns, improving healthcare ecosystem.
My career is fueled by a passion for advancing healthcare innovation, improving patient outcomes, and fostering collaborations. Whether launching therapies or reshaping systems, I am committed to delivering patient-centric solutions.
π€πΌLetβs connect to explore opportunities, share expertise, and collaborate on impactful healthcare strategies.
English
Fluent
Remote only
Primarily works remotely
Experience
- Italfarmaco,Medical DirectorMay 2025 - Today (1 year and 1 month)Dubai - United Arab Emiratesβ’ β’ Leading regional medical launch readiness for first-in-class DMD therapy (Givinostat) across Gulf and Saudi Arabia, defining disease landscape, patient segmentation, and scientific positioning.β’ β’ Built and activated a neuromuscular KOL network across the GCC, engaging ~150β170 HCPs through structured scientific exchanges, advisory discussions, and regional and international lectures.β’ β’ Supporting regulatory and payer preparedness by contributing to Saudi pricing and value discussions, budget impact considerations, and early engagement with MOH-linked neurologists and neurogeneticists.β’ β’ Established Gulf and KSA medical capability from the ground up, including MSL recruitment, medical governance, reporting standards, and compliant speaker engagement models ahead of launch.
- Pfizer,Medical Affairs Scientist (Level 2)January 2022 - October 2024 (2 years and 9 months)Ontario, Canadaβ’ β’ Developed peer-to-peer relationships with KOLs and other HCPs to establish and maintain the therapeutic leadership position in the evolving dermatology landscape.β’ β’ Successfully launched Abrocitinib in 2022 and first in class molecule in alopecia areata, Ritlecitinib in 2024 by leading scientific work on the dermatology portfolio, with focus on medical leadership, and pre-launch strategy.β’ β’ Led the development and approval of a CAD 100,000 educational grant to empower emerging women dermatologists in Canada through a long-term training program focused on digital opinion leadership.
- Pfizer Upjohn,Regional Portfolio LeadJanuary 2019 - May 2021 (2 years and 4 months)Dubai - United Arab Emiratesβ’ β’ Built a strong regional medical community through ENACT (Empowering NCD Action), engaging over 1,500 healthcare professionals through 7 educational platforms, advisory boards, and partnerships with health authoritiesβ’ β’ Led the Mapping the Patient Journey (MAPS) project, addressing non-communicable diseases (NCDs) in 4 countries. This initiative generated actionable insights to improve healthcare systems and resulted in four peer reviewed publications, advancing evidence-based approaches for managing hypertension and dyslipidemia across the region.β’ β’ Upskilled medical team with focus on growth and capability development of country colleagues (n=12)β’ β’ Member of Upjohn medical affairs curriculum committee for review and endorsement of training curriculum for emerging markets
Recommendations
Be the first to recommend Kanwal
Help this freelancer shine by sharing your experience working together.
These freelancer profiles also match your criteria
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Education
- MBA (Masters of Business Administration)Institute of Business Administration2012
- MBBS (Bachelors of Medicine, Bachelors of Surgery)Ziauddin Medical University2008